Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes

By sjmartinez • April 15, 2025

Zelada H, Campana M, Kawai K, Redden D, Agarwal G, Gutierrez OM, Kumar V. Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes. Clin Transplant. 2025 Apr;39(4):e70144. doi: 10.1111/ctr.70144. PMID: 40230336.

Tags: allograft, diabetes, DOM STAT, Endocrinology, Function, General Internal Medicine, kidney, kidney (allograft) function, posttransplant, Publications

Population health management of diabetic kidney disease in Los Angeles county municipal health system

Kalantar-Zadeh K, Friedman TC, Jafari G, Ghaffari A, Khine A, Nicholas SB, Rhee CM, Dhamija R, Raff EA. Population health management of diabetic kidney disease[...]

Understanding the Link Between Patient Symptoms and Provider Goals for Mucosal Healing in IBD: Insights from the IBD Qorus Survey

Troia A, Harvey S, Wu A, Kiparizoska S, Weaver A, Oberai R, Melmed GY, Siegel CA, Singh S, Mattar MC. Understanding the Link Between Patient[...]

Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents

Wang SY, Stofer R, Wang H, Brent GA, Shi L, Cai Y, Roosan M, Moin T. Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist[...]